Acosta S, Reintam Blaser A, Nuzzo A, Soltanzadeh-Naderi Y, Starkopf J, Forbes A
Biomark Insights. 2024; 19:11772719241296631.
PMID: 39600492
PMC: 11590162.
DOI: 10.1177/11772719241296631.
King K, Cai S, Barrera L, Reddy P, Heneghan M, Badawy S
Pediatr Blood Cancer. 2023; :e30440.
PMID: 37243925
PMC: 10679470.
DOI: 10.1002/pbc.30440.
Kang H, Dietrich E, Huang P, Lo-Ciganic W, DeRemer C, Park H
Clin Transl Sci. 2023; 16(6):946-954.
PMID: 36891985
PMC: 10264957.
DOI: 10.1111/cts.13510.
Delavar A, Baxter S
BMJ Case Rep. 2022; 15(11).
PMID: 36384882
PMC: 9670929.
DOI: 10.1136/bcr-2022-249509.
Schulz A, Herrmann E, Ott O, Lindhoff-Last E
J Clin Med. 2022; 11(16).
PMID: 36013082
PMC: 9409774.
DOI: 10.3390/jcm11164845.
Deceptive Adherence to Anticoagulation in Secondary Stroke Prevention.
Vibo R, Kuningas J, Tsakuhhin P, Korv J
Stroke Res Treat. 2022; 2022:5318259.
PMID: 35859782
PMC: 9293572.
DOI: 10.1155/2022/5318259.
Individual risk factors predictive of major trauma in pre-hospital injured older patients: a systematic review.
Pandor A, Fuller G, Essat M, Sabir L, Holt C, Woods H
Br Paramed J. 2022; 6(4):26-40.
PMID: 35340581
PMC: 8892449.
DOI: 10.29045/14784726.2022.03.6.4.26.
Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registry.
Speed V, Auyeung V, Patel J, Cooper D, Miller S, Roberts L
Res Pract Thromb Haemost. 2021; 5(8):e12614.
PMID: 34849447
PMC: 8606029.
DOI: 10.1002/rth2.12614.
Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?.
Toorop M, Chen Q, Kruip M, van der Meer F, Nierman M, Faber L
J Thromb Haemost. 2021; 20(2):339-352.
PMID: 34779140
PMC: 9299168.
DOI: 10.1111/jth.15592.
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial.
Woller S, Stevens S, Kaplan D, Wang T, Branch D, Groat D
Blood Adv. 2021; 6(6):1661-1670.
PMID: 34662890
PMC: 8941474.
DOI: 10.1182/bloodadvances.2021005808.
Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation.
Charlton A, Vidal X, Sabate M, Bailarin E, Martinez L, Ibanez L
J Manag Care Spec Pharm. 2021; 27(9):1210-1220.
PMID: 34464214
PMC: 10391044.
DOI: 10.18553/jmcp.2021.27.9.1210.
A Patient Decision Aid for Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Development and Pilot Study.
de Castro K, Chiu H, De Leon-Yao R, Almelor-Sembrana L, Dans A
JMIR Cardio. 2021; 5(2):e23464.
PMID: 34385138
PMC: 8391739.
DOI: 10.2196/23464.
Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel.
Tesfaye W, Erku D, Mekonnen A, Tefera Y, Castelino R, Sud K
J Nephrol. 2021; 34(4):1091-1125.
PMID: 33559850
DOI: 10.1007/s40620-020-00895-x.
Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range.
Marcatto L, Boer B, Sacilotto L, Olivetti N, Darrieux F, Scanavacca M
J Thromb Thrombolysis. 2020; 51(4):1043-1049.
PMID: 32974757
DOI: 10.1007/s11239-020-02280-8.
A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.
Speed V, Patel R, Byrne R, Roberts L, Arya R
Thromb Res. 2020; 192:73-74.
PMID: 32425265
PMC: 7229971.
DOI: 10.1016/j.thromres.2020.05.024.
Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.
Boon G, van Rein N, Bogaard H, Ende-Verhaar Y, Huisman M, Kroft L
PLoS One. 2020; 15(4):e0232354.
PMID: 32343741
PMC: 7188241.
DOI: 10.1371/journal.pone.0232354.
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.
Zielinski G, van Rein N, Teichert M, Klok F, Rosendaal F, van der Meer F
Res Pract Thromb Haemost. 2020; 4(1):141-153.
PMID: 31989096
PMC: 6971315.
DOI: 10.1002/rth2.12261.
Evaluation of a program of pharmaceutical counseling for French patients on oral anticoagulant therapy.
Roseau C, Richard C, Renet S, Kowal C, Eliahou L, Rieutord A
Int J Clin Pharm. 2020; 42(2):685-694.
PMID: 31933106
DOI: 10.1007/s11096-020-00964-y.
Warfarin Use and Mortality, Stroke, and Bleeding Outcomes in a Cohort of Elderly Patients with non-Valvular Atrial Fibrillation.
Pamela J B, Joseph H, Matthew K, Thomas G B, Lee N, Judith M K
J Atr Fibrillation. 2019; 12(1):2155.
PMID: 31687068
PMC: 6811337.
DOI: 10.4022/jafib.2155.
Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal.
Lowres N, Giskes K, Hespe C, Freedman B
Korean Circ J. 2019; 49(10):883-907.
PMID: 31535493
PMC: 6753021.
DOI: 10.4070/kcj.2019.0234.